Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-05-17 @ 11:04 PM
Study NCT ID:
NCT06322095
Status:
RECRUITING
Last Update Posted:
2024-10-01
First Post:
2024-03-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors
Sponsor:
Suzhou Genhouse Bio Co., Ltd.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GH21C202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None